ResearcherCedars-Sinai Medical CenterActive in the last 2 years
Ruoxiang Wang
Matched on ORCID iD 0000-0003-2614-8292; OpenAlex author ID A5020873093. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 7
- Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. Co-author DOI 10.1038/s41598-026-66961-9↗
- Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters. First author DOI 10.1016/j.canlet.2025.217546↗
- Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal ade… Co-author DOI 10.3389/fonc.2025.1611872↗
- Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsy. Co-author DOI 10.1038/s44276-024-00069-3↗
- Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1002/adtp.202200021↗
- Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples. Co-author DOI 10.3389/fphys.2022.827531↗
- The Potential for Circulating Tumor Cells in Pancreatic Cancer Management. Co-author DOI 10.3389/fphys.2017.00381↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen Jacob Pandol · 7 shared papers, 2017–2026 · strength 1.36
- Paper Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. DOI 10.1038/s41598-026-66961-9↗
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood sample… DOI 10.3389/fonc.2025.1611872↗
- Mouad Edderkaoui · 4 shared papers, 2017–2026 · strength 0.79
- Paper Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. DOI 10.1038/s41598-026-66961-9↗
- Paper Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood sample… DOI 10.3389/fonc.2025.1611872↗
- Paper Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1002/adtp.202200021↗
- Yan Ou · 3 shared papers, 2022–2026 · strength 0.69
- Paper Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. DOI 10.1038/s41598-026-66961-9↗
- Paper Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood sample… DOI 10.3389/fonc.2025.1611872↗
- Paper Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1002/adtp.202200021↗
- Simon K. Lo · 3 shared papers, 2024–2025 · strength 0.65
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood sample… DOI 10.3389/fonc.2025.1611872↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Stephanie N. Shishido · 2 shared papers, 2024–2025 · strength 0.42
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Peter Kühn · 2 shared papers, 2024–2025 · strength 0.42
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Aurelia Lugea Reta · 1 shared paper, 2025 · strength 0.23
- Rabindra R. Watson · 1 shared paper, 2025 · strength 0.23
- Richard T. Waldron · 1 shared paper, 2025 · strength 0.23
- Srinivas Gaddam · 1 shared paper, 2025 · strength 0.23
- Yi Zhang · 1 shared paper, 2022 · strength 0.16
- Omer Hany Miligy Elmadbouh · 1 shared paper, 2022 · strength 0.16
- Nicholas N. Nissen · 1 shared paper, 2022 · strength 0.15
- James S. Tomlinson · 1 shared paper, 2022 · strength 0.15
- Michael Pimienta · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.